摘要
目前,由于无毒低放射性药物的应用,核医学已为内科各个专业提供了诊断和治疗技术。由于核医学专家、化学家、物理学家、核物理学家、放射化学家及放射性药物学家们的交叉协作,已使核医学特有的显像(包括受体及抗原定位)功能成为现实。新的放射性药物及附有计算机的先进显像设备的发展,使临床上某些重要领域取得显著进展。
Development of nuclear medicine depends on the development of radiopharmaceuticals and nuclear medicine instruments. Radiopharmaceuticals are the agents for diagnosis or therapy in nuclear medicine. The main nuclide for clinical diagnosis is reactor-produced metastable technetium-99 (^(99)Tc^m). Cyclotron-produced nuclides ^(201)TI, ^(67)Ga, ^(111)In, ^(123)I and short lived positron emitting nuclides ^(?)C. ^(13)N. ^(15)O. ^(18)F are important, too. A few radiopharmaceuticais with higher-energy beta-emitti...
出处
《同位素》
CAS
北大核心
1992年第3期167-192,共26页
Journal of Isotopes
关键词
放射性药物
核素
核医学
显像
radiopharmaceutical
nuclide
nuclear medicine
imaging.
